BPH Medication
Treatment
in Seomyeon, Busan
📍 Seomyeon, Busanjin-gu, Busan | 🚇 Seomyeon Station Exit 5 | 🌐 English OK | 💊 Prescription Service
Medication-based treatment for BPH (benign prostatic hyperplasia / enlarged prostate) at Urogyn Men's Clinic in Seomyeon, Busan — alpha-blockers, 5-alpha reductase inhibitors, and PDE5 inhibitors prescribed by a board-certified urologist. Full diagnostic workup (IPSS, uroflowmetry, PSA, ultrasound). English consultations. Long-term follow-up available remotely via WhatsApp after your initial visit.
BPH medication at Urogyn Seomyeon, Busan — 3 drug classes: alpha-blockers(fast relief 1-2 weeks), 5-ARIs(shrink prostate over 3-6 months), and PDE5i(BPH + erection together). Combination therapy for moderate-severe cases. Full diagnostic workup including PSA cancer screening. English OK.
Confidential · International patients welcome
What Is BPH (Benign Prostatic Hyperplasia)?
Normal prostate (left) vs enlarged prostate (right) compressing the urethra and causing urinary symptoms.
BPH (benign prostatic hyperplasia) is a non-cancerous enlargement of the prostate gland — a walnut-sized male reproductive organ located just below the bladder, surrounding the urethra. As the prostate enlarges with age, it progressively compresses the urethra, obstructing urine flow and causing a characteristic group of symptoms known as lower urinary tract symptoms (LUTS). BPH is extremely common: approximately 50% of men aged 51-60 and over 90% of men over 80 have some degree of prostatic enlargement. For most men, symptom severity determines whether treatment is needed.
Medication is the first-line treatment for mild-to-moderate BPH and an essential adjunct in many surgical cases. Three distinct drug classes address BPH through different mechanisms: alpha-blockers relax the smooth muscle around the urethra for immediate symptom relief, 5-alpha reductase inhibitors shrink the prostate itself over several months, and PDE5 inhibitors (taken daily) simultaneously improve BPH symptoms and erectile function. For moderate-to-severe BPH, combination therapy using an alpha-blocker plus a 5-ARI is the clinically validated gold standard.
Common BPH Symptoms (Lower Urinary Tract Symptoms)
Weak Stream
Reduced urinary force or flow strength compared to years ago.
Hesitancy
Difficulty starting the urinary stream despite the urge to urinate.
Intermittency
Stream stops and starts during a single urination attempt.
Incomplete Emptying
Feeling that the bladder has not fully emptied after urination.
Frequency
Needing to urinate more often than previously (day and night).
Urgency
Sudden, difficult-to-defer urge to urinate.
Nocturia
Waking 2+ times per night specifically to urinate.
Post-Void Dribble
Persistent dribbling after apparent completion of urination.
IPSS — International Prostate Symptom Score
Symptom severity is measured using the IPSS (International Prostate Symptom Score), a validated 7-question questionnaire scored 0-35. Your IPSS score determines treatment recommendations. At consultation, the urologist will complete the IPSS with you and interpret it alongside uroflowmetry, PSA, and ultrasound findings to design an individualised treatment plan.
Lifestyle modification and observation. Medication considered if symptoms are bothersome.
Medication is first-line treatment. Alpha-blocker alone, or combination therapy if prostate is enlarged.
Combination medication therapy. Surgical options (Urolift, Rezum, TURP) also considered.
3 Main BPH Drug Classes
BPH medication treatment uses three distinct drug classes, each working through a different mechanism. Your urologist selects the appropriate medication — or combination — based on your IPSS score, prostate volume, age, sexual function goals, and medical history.
Alpha-Blockers
Tamsulosin · Silodosin · Alfuzosin · TerazosinAlpha-blockers relax the smooth muscle of the prostate capsule, prostatic urethra, and bladder neck. This mechanical relaxation opens the urethral passageway, producing rapid symptom improvement within 1-2 weeks. They are the most commonly prescribed BPH medication and the standard first-line therapy for moderate symptoms. Unlike 5-ARIs, alpha-blockers do not shrink the prostate — they improve flow by relaxing the muscles.
- Onset: 1–2 weeks for noticeable improvement
- IPSS reduction: typically 4–6 points
- Daily dose: once daily, evening preferred
- Side effects: dizziness, retrograde ejaculation (tamsulosin)
- Best for: symptom relief regardless of prostate size
5-Alpha Reductase Inhibitors
Finasteride · Dutasteride5-ARIs block the enzyme 5-alpha reductase, which converts testosterone to DHT (dihydrotestosterone) — the hormone driving prostate growth. By reducing DHT, these medications shrink the prostate volume by 20-30% over 3-6 months. Unlike alpha-blockers, 5-ARIs address the underlying cause rather than just symptoms, making them particularly valuable for larger prostates (over 40mL) and for preventing BPH progression or acute urinary retention.
- Onset: 3–6 months for maximum effect
- Prostate shrinkage: 20–30% volume reduction
- Daily dose: once daily, any time
- Side effects: reduced libido (minority), lowers PSA by 50%
- Best for: larger prostates, progression prevention
PDE5 Inhibitors
Tadalafil 5mg Daily (Cialis daily)Tadalafil taken as a daily low-dose (5mg) simultaneously treats BPH and erectile dysfunction — a significant advantage for men with both conditions (which frequently coexist). The mechanism involves smooth muscle relaxation in the prostate, bladder, and penile vasculature. FDA-approved specifically for BPH at this dose. Unlike alpha-blockers, there is no retrograde ejaculation risk.
- Onset: 2–4 weeks for BPH improvement
- Dual benefit: treats BPH + ED together
- Daily dose: 5mg once daily, same time
- Side effects: headache (transient), flushing
- Contraindicated with: nitrates (heart disease)
Combination Therapy — The Gold Standard
For men with moderate-to-severe BPH and enlarged prostate volume (over 40mL), combination therapy (alpha-blocker + 5-ARI) produces superior outcomes to either drug alone. Large clinical trials (MTOPS, CombAT) have demonstrated that combination therapy reduces progression risk, acute retention episodes, and need for BPH surgery by over 60% compared to alpha-blocker monotherapy. At Urogyn Busan, combination therapy is recommended for IPSS scores ≥12 with prostate volume >40mL.
Your Treatment Timeline
Understanding the expected timeline helps set realistic expectations and maintain medication adherence. Below is the standard progression for men starting BPH medication at Urogyn Busan.
Start Medication
Initial prescription. Minor side effects may emerge (adjust with food or timing).
First Improvement
Alpha-blocker effect noticeable — faster stream, less urgency, reduced nocturia.
Follow-Up IPSS
Repeat IPSS to quantify improvement. Adjust medication if needed.
Full Effect
5-ARI prostate shrinkage maximised. Long-term stable symptom control established.
Initial Diagnostic Workup
Before starting medication, a comprehensive baseline assessment is performed. This ensures correct diagnosis (ruling out prostate cancer, bladder cancer, or other conditions mimicking BPH) and provides baseline measurements to track treatment response over time.
- IPSS questionnaire — standardised 7-question symptom scoring
- Uroflowmetry — non-invasive flow rate measurement
- Post-void residual ultrasound — measures urine left in bladder after urination
- Prostate volume ultrasound — determines if prostate is enlarged (normal under 25mL)
- PSA blood test — prostate cancer screening (elevated PSA warrants further workup)
- Digital rectal examination (DRE) — clinical assessment of prostate size, shape, and texture
- Urinalysis — rules out infection or haematuria that may mimic BPH symptoms
When Medication Is Not Enough
For some patients, medication produces inadequate relief or causes intolerable side effects. Urogyn Busan offers the full range of surgical BPH treatments as next-step options: Urolift(minimally invasive implant that holds prostate tissue open), Rezum(water vapour thermotherapy that destroys excess tissue), and TURP(traditional transurethral resection for larger prostates). Transitioning from medication to surgery when appropriate is discussed at follow-up visits.
Urogyn's 7-Point Care Standard
Comprehensive Diagnostic Workup
IPSS, uroflowmetry, PSA, prostate ultrasound, urinalysis, and DRE at baseline — no shortcuts.
Prostate Cancer Screening
PSA and DRE at every visit. Elevated PSA or abnormal DRE triggers multiparametric MRI and biopsy workup.
Individualised Drug Selection
Medication chosen based on your specific IPSS, prostate volume, age, sexual function goals, and comorbidities.
Side-Effect Monitoring
Proactive questioning about side effects at every follow-up. Dose adjustment or drug switching as needed.
Drug Interaction Review
Full medication review at consultation. PDE5 + nitrate contraindication, alpha-blocker + BP-medication review.
Long-Term Follow-Up
3-6 month intervals. IPSS repeated annually. PSA repeated per clinical guidelines.
Surgical Escalation Planning
When medication fails, Urolift / Rezum / TURP options discussed — full surgical service in-house.
International Patient Support
Prescription management, English records, and WhatsApp follow-up available after you return home.
Who Should Consider BPH Medication?
✓ Good Candidates
- Men experiencing LUTS symptoms (weak stream, hesitancy, frequency, nocturia)
- IPSS score 8-20 with bothersome symptoms affecting quality of life
- Men who prefer non-surgical first-line treatment
- Patients with BPH and coexisting erectile dysfunction (ideal for PDE5i)
- International patients seeking specialist urological assessment with English support
- Men wishing to prevent progression to urinary retention or need for surgery
⚠ Medication May Not Be Sufficient
- IPSS score 25+ with severe symptoms significantly impacting life
- Acute urinary retention requiring catheterisation
- Recurrent urinary infections due to incomplete bladder emptying
- Bladder stones or kidney damage from chronic obstruction
- Prostate volume significantly enlarged (over 80mL) — surgery often superior
- Failure or intolerable side effects on previous medication trials
Frequently Asked Questions
Common questions from international patients considering BPH medication treatment in Busan, Korea.
What is BPH and what are the symptoms?
What medications are used to treat BPH?
How long until I feel improvement from BPH medication?
Are BPH medications safe for long-term use?
Will I need to take BPH medication forever?
Can I take BPH medication along with my other prescriptions?
Is prostate cancer screening included with BPH treatment?
How much does BPH medication treatment cost in Busan?
Book Your BPH
Consultation Today — English OK
Board-certified urologist in Seomyeon, Busan. Complete diagnostic workup. PSA cancer screening. Private & confidential.